Cipher Pharmaceuticals (CPHRF) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free CPHRF Stock Alerts $6.37 -0.09 (-1.39%) (As of 05/17/2024 08:55 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Cipher Pharmaceuticals Short Interest DataCurrent Short Volume20,000 sharesPrevious Short Volume13,100 sharesChange Vs. Previous Month+52.67%Dollar Volume Sold Short$127,200.00Short Interest Ratio / Days to Cover1.3Last Record DateApril 30, 2024Today's Trading Volume6,700 sharesAverage Trading Volume16,762 sharesToday's Volume Vs. Average40% Short Selling Cipher Pharmaceuticals ? Sign up to receive the latest short interest report for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCPHRF Short Interest Over TimeCPHRF Days to Cover Over TimeCPHRF Percentage of Float Shorted Over Time Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Cipher Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202420,000 shares $127,200.00 +52.7%N/A1.3 $6.36 4/15/202413,100 shares $88,949.00 -16.6%N/A0.4 $6.79 3/31/202415,700 shares $103,472.42 +34.2%N/A0.2 $6.59 3/15/202411,700 shares $61,659.00 +265.6%N/A0.2 $5.27 2/29/20243,200 shares $16,672.32 +6.7%N/A0.1 $5.21 2/15/20243,000 shares $16,140.00 -45.5%N/A0.1 $5.38 Get the Latest News and Ratings for CPHRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20245,400 shares $23,652.00 +217.7%N/A0.6 $4.38 12/31/20231,700 shares $7,123.00 -66.7%N/A0.1 $4.19 12/15/20235,100 shares $23,970.00 +218.8%N/A0.3 $4.70 11/30/20231,600 shares $7,072.00 No ChangeN/A0.1 $4.42 11/15/20231,600 shares $6,352.00 -70.9%N/A0 $3.97 10/31/20235,500 shares $17,277.15 +223.5%N/A0.8 $3.14 10/15/20231,700 shares $5,253.00 +1,600.0%N/A0.2 $3.09 9/30/2023100 shares $318.47 -90.9%N/A0 $3.18 9/15/20231,100 shares $3,630.11 -15.4%N/A0.1 $3.30 8/31/20231,300 shares $3,783.00 +44.4%N/A0.2 $2.91 8/15/2023900 shares $2,412.00 No ChangeN/A0.1 $2.68 6/15/2023900 shares $2,512.62 No ChangeN/A0.6 $2.79 5/15/20231,000 shares $2,590.00 No ChangeN/A0.1 $2.59 4/15/2023900 shares $2,277.00 -76.3%N/A0.1 $2.53 3/31/20233,800 shares $9,386.00 No ChangeN/A0.2 $2.47 2/15/20231,000 shares $2,760.00 +11.1%N/A0.1 $2.76 1/31/2023900 shares $2,286.00 No ChangeN/A0.1 $2.54 1/15/2023900 shares $2,480.22 -43.8%N/A0.1 $2.76 12/30/20221,600 shares $4,471.84 -33.3%N/A0.4 $2.79 12/15/20222,400 shares $6,707.04 +9.1%N/A0.4 $2.79 11/30/20222,200 shares $5,610.00 -4.4%N/A0.2 $2.55 11/15/20222,300 shares $5,839.93 -28.1%N/A0.3 $2.54 10/31/20223,200 shares $7,588.48 +60.0%N/A0.5 $2.37 10/15/20222,000 shares $4,381.60 +33.3%N/A0.3 $2.19 9/30/20221,500 shares $3,450.00 -46.4%N/A0.1 $2.30 9/15/20222,800 shares $6,524.00 +1,300.0%N/A0.3 $2.33 8/31/2022200 shares $380.00 -33.3%N/A0.1 $1.90 8/15/2022300 shares $550.89 -40.0%N/A0 $1.84 7/31/2022500 shares $855.00 No ChangeN/A0.1 $1.71 7/15/2022500 shares $850.00 -16.7%N/A0.2 $1.70 6/30/2022600 shares $1,019.34 No ChangeN/A0.2 $1.70 6/15/2022600 shares $1,122.00 -50.0%N/A0.1 $1.87 5/31/20221,200 shares $2,211.47 +50.0%N/A1.2 $1.84 5/15/2022800 shares $1,504.00 No ChangeN/A0.1 $1.88Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… CPHRF Short Interest - Frequently Asked Questions What is Cipher Pharmaceuticals' current short interest? Short interest is the volume of Cipher Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 20,000 shares of CPHRF short. Learn More on Cipher Pharmaceuticals' current short interest. What is a good short interest ratio for Cipher Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CPHRF shares currently have a short interest ratio of 1.0. Learn More on Cipher Pharmaceuticals's short interest ratio. Is Cipher Pharmaceuticals' short interest increasing or decreasing? Cipher Pharmaceuticals saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 20,000 shares, an increase of 52.7% from the previous total of 13,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cipher Pharmaceuticals stock? Short selling CPHRF is an investing strategy that aims to generate trading profit from Cipher Pharmaceuticals as its price is falling. CPHRF shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cipher Pharmaceuticals? A short squeeze for Cipher Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CPHRF, which in turn drives the price of the stock up even further. How often is Cipher Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPHRF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: 1933 Industries Short Interest 4Cable TV International Short Interest 4Front Ventures Short Interest AB Science Short Interest Acreage Short Interest Acreage Short Interest Aleafia Health Short Interest Almirall Short Interest Alvotech Short Interest American Green Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CPHRF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyShocking: One AI startup's revenue could surge 4,735%Manward PressUrgent Nvidia WarningAltimetry"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA once-in-a-century investment opportunityStansberry Research